Market Cap

Almirall, SA Market Capitalization:

€2.77 Billion

EUR as of Jan. 1, 2026

US$3.25 Billion

business Almirall, SA Company Profile

Almirall, SA Main Stock Listing

BME: ALM

Market Capitalization History of Almirall, SA

Market capitalizations are calculated from the opening stock price at the beginning of each month.

Top Competitors by Market Capitalization

Industry: Drug Manufacturers—Specialty & Generic
Company Market Cap (USD)
MERCK Kommanditgesellschaft auf Aktien $62.01 B
Zoetis Inc. $55.81 B
Takeda Pharmaceutical Company Limited $45.42 B
Haleon plc $44.50 B
Teva Pharmaceutical Industries Limited $35.85 B
Sector: Healthcare
Company Market Cap (USD)
Lilly $968.50 B
Johnson & Johnson $499.57 B
AbbVie $405.28 B
Roche $332.12 B
UnitedHealth Group $304.72 B

Yearly evolution of Almirall, SA market cap

Date Market Cap YoY Change
Jan. 1, 2026 €2.77 B 48.33%
Jan. 1, 2025 €1.87 B 4.50%
Jan. 1, 2024 €1.79 B 6.17%
Jan. 1, 2023 €1.68 B -20.76%
Jan. 1, 2022 €2.12 B 0.98%
Jan. 1, 2021 €2.10 B

Market capitalization is calculated from the opening stock price at the beginning of each year.

Almirall, SA Categories

Spain languages Healthcare languages Drug Manufacturers—Specialty & Generic
Spain Healthcare Spain Drug Manufacturers—Specialty & Generic

Stocks & Indices

Almirall, SA has the following listings and related stock indices.


Stock: BME: ALM

Stock: FSX: E2Z

What is a company's market capitalization?

The market capitalization of a company, more simply referred to as "market cap", is the total market value of a publicly traded company's outstanding shares. It is often considered as a key indicator of what a company is worth.